Recommended Products
usage
10 reactions
availability
not available in Japan
storage temp.
2-8°C
Related Categories
General description
AnteoTech identified the following problems that researchers are having with their multiplex assays:
From these findings, they developed the AnteoBind™ Activation Kit For Multiplex Microspheres that is for use with the Luminex xMAP® system and contains the patented AnteoBind Activation Reagent.
With this Activation Kit, you can couple multiple antibodies without extra optimization for each, saving assay development time and reducing the barriers of assay transfer between diverse platforms.
AnteoBind is water based and replaces the dry chemicals you would use with the EDC method. Using AnteoBind instead of NHS/EDC chemistry can save up to 3-4 hours of lab time. Experiments have shown increased stability and functionality for antibodies and a decreased background. AnteoBind improves reproducibility between experiments by providing uniformity between surfaces. You can store your AnteoBind activated microspheres for up to 1 year.
POSTER: A Novel User Friendly Chemistry to Couple Antibodies and Challenging Proteins to Luminex MagPlex Microspheres
- Binding difficult antibodies and antigens to microspheres
- Complex protocols for inexperienced users
- Lengthy microsphere and protein preparation times prior to protein coupling
- Reproducibility between batches of protein coupled microspheres
- Limited storage of ready-to-couple microspheres
From these findings, they developed the AnteoBind™ Activation Kit For Multiplex Microspheres that is for use with the Luminex xMAP® system and contains the patented AnteoBind Activation Reagent.
With this Activation Kit, you can couple multiple antibodies without extra optimization for each, saving assay development time and reducing the barriers of assay transfer between diverse platforms.
AnteoBind is water based and replaces the dry chemicals you would use with the EDC method. Using AnteoBind instead of NHS/EDC chemistry can save up to 3-4 hours of lab time. Experiments have shown increased stability and functionality for antibodies and a decreased background. AnteoBind improves reproducibility between experiments by providing uniformity between surfaces. You can store your AnteoBind activated microspheres for up to 1 year.
POSTER: A Novel User Friendly Chemistry to Couple Antibodies and Challenging Proteins to Luminex MagPlex Microspheres
Application
Activation and coupling of Luminex Microspheres for Multiplex Immunoassays
Features and Benefits
- Water based AnteoBind™ activation and coupling reagent for microspheres
- Fast assay development time making it easy to move your ELISA assay to the Luminex xMAP® system
- Compatible with both Luminex MagPlex® and MicroPlex® microspheres
- Test problematic proteins on xMAP, including those cited as not suitable for the system
- An alternative to traditional chemistries such as NHS/EDC methods with an easier to use AnteoBind protocol
- Ease of use, simply pipette AnteoBind Reagent to your chosen microspheres to activate
- Reduce reagent preparation time by 3-4 hours
- Increase antibody functionality
- Low background noise
- High reproducibility between experiments
Legal Information
Anteobind is a trademark of AnteoTech Ltd
MagPlex is a registered trademark of Luminex Corp
MicroPlex is a registered trademark of Luminex Corp
xMAP is a registered trademark of Luminex Corp
Kit Components Only
Product No.
Description
- Mix&Go Activation Reagent
- Coupling Buffer
- Storage Buffer
- Low Binding Microcentrifuge Tubes
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Aquatic Chronic 2 - Skin Sens. 1
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
新产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Katrin Bohm et al.
Vaccine, 35(43), 5883-5889 (2017-09-19)
Worldwide about 1.5 million clinical cases of hepatitis A virus (HAV) infections occur every year and increasingly countries are introducing HAV vaccination into the childhood immunization schedule with a single dose instead of the originally licenced two dose regimen. Diagnosis
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service